Non-Invasive Respiratory Monitor

NCT ID: NCT02851043

Last Updated: 2025-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-08-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will clinically evaluate a newly developed respiratory monitor - pneuRIP. The pneuRIP uses Respiratory Inductance Plethysmography (RIP) bands to measure key breathing indices non-invasively. This study compares the pneuRIP to an existing Respitrace system (Carefusion, Yorba Linda CA). 10 normal children and 10 children with breathing difficulties will be monitored with both systems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Firstly, ten healthy children will participate in a trial to evaluate the pneuRIP. They will be fitted with the bands around their abdomen and chest. The pneuRIP will be connected to the bands through electrodes. Breathing is then measured wirelessly with an iPad. They will be asked to lie down. They are asked to breath normally then asked to breath with a resistive elements to place in their mouth. The resistive elements makes it difficult to breath (similar to breathing through a straw). They will breathe for 3 minutes for both conditions as we record their breathing with the pneuRIP and the Respitrace. These data will be compared.

Secondly, A group of 10 subjects from the outpatient muscle clinic will be fitted with the chest and abdomen bands. The Respitrace monitor and the pneuRIP will record their breathing patterns. Data from the two systems will then be compared.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Diseases Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pneuRIP(breathing with resistance)

Testing the subjects breathing with resistance

Group Type EXPERIMENTAL

pneuRIP (breathing with resistance)

Intervention Type DEVICE

subjects are given a resistance element to breath through

Respitrace system (Carefusion) (breathing without resistance)

Intervention Type DEVICE

subjects are asked to breath normally

Respitrace system (Carefusion) (breathing without resistance)

Testing subjects breathing without resistance

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pneuRIP (breathing with resistance)

subjects are given a resistance element to breath through

Intervention Type DEVICE

Respitrace system (Carefusion) (breathing without resistance)

subjects are asked to breath normally

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteers
* Neuromuscular disease subjects with mild breathing difficulty
* Capable of following verbal instructions

Exclusion Criteria

* Severe breathing difficulties
Minimum Eligible Age

11 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nemours Children's Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tariq Rahman

Principal Research Engineer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Shaffer, PhD

Role: PRINCIPAL_INVESTIGATOR

Nemours

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nemours/A.I. duPont Hospital for Children

Wilmington, Delaware, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tariq Rahman, PhD

Role: CONTACT

302 651 6831

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tariq Rahman, PhD

Role: primary

302-651-6831

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

613308

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.